European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterone acetate - prostatic neoplasms - endocrine therapy - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

European Union - English - EMA (European Medicines Agency)

mylan ireland limited - abiraterone acetate - prostatic neoplasms - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated.the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

European Union - English - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterone acetate - prostatic neoplasms - endocrine therapy - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5.1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5.1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abiraterone acetate is cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).

Israel - English - Ministry of Health

teva israel ltd - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abiraterone acetate is a cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).

Israel - English - Ministry of Health

abic marketing ltd, israel - abiraterone acetate - tablets - abiraterone acetate 500 mg - abiraterone - abiraterone teva is indicated:1. in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.2. for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abiraterone trima 250 mg is a cyp17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - abiraterone acetate - film-coated tablet - 250 milligram(s) - abiraterone

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - abiraterone acetate - film-coated tablet - 500 milligram(s) - abiraterone

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - abiraterone acetate - tablet - 250 milligram(s) - abiraterone